Medicinal Products

343. Deputy Michael Cahill asked the Minister for Health to clarify the position in relation to blister packs, including any associated costs; and if she will make a statement on the matter. [44783/26]

347. Deputy Cathal Crowe asked the Minister for Health the status of price negotiations between the Health Service Executive Corporate Pharmaceutical Unit and the manufacturer regarding the reimbursement of omaveloxolone (skyclarys) for the treatment of Friedreich's ataxia; if she will address concerns regarding the omission of this life-altering therapy from the immediate agenda of the HSE Drugs …

349. Deputy Cathal Crowe asked the Minister for Health the status of the reimbursement process for the medication givinostat (duvyzat) for patients living with Duchenne muscular dystrophy (DMD); if she will provide an update on the outcome of the HSE Drugs Group meeting scheduled for 10 June 2026; the timeline for a final decision by the HSE leadership; if she will ensure that the clinical eligibi…

350. Deputy Michael Cahill asked the Minister for Health to ensure that all children within the State receive urgent access to givinostat (duvyzat) for Duchenne muscular dystrophy (details supplied); and if she will make a statement on the matter. [44837/26]

355. Deputy Michael Healy-Rae asked the Minister for Health to review medication on the drugs payment scheme for a person (details supplied); and if she will make a statement on the matter. [44849/26]

356. Deputy Colm Burke asked the Minister for Health when the HSE will make a decision on reimbursement for the drug givinostat for patients with Duchenne muscular dystrophy; and if she will make a statement on the matter. [44850/26]

357. Deputy Colm Burke asked the Minister for Health to provide an update on the availability of the drug givinostat for patients with Duchenne muscular dystrophy; and if she will make a statement on the matter. [44851/26]

360. Deputy Michael Cahill asked the Minister for Health to ensure that all children within the State receive urgent access to givinostat (duvyzat) for Duchenne muscular dystrophy (details supplied); and if she will make a statement on the matter. [44860/26]

361. Deputy Michael Cahill asked the Minister for Health to ensure that all children within the State receive urgent access to givinostat (duvyzat) for Duchenne muscular dystrophy (details supplied); and if she will make a statement on the matter. [44861/26]

362. Deputy Michael Cahill asked the Minister for Health to ensure that all children within the State receive urgent access to givinostat (duvyzat) for Duchenne muscular dystrophy (details supplied); and if she will make a statement on the matter. [44863/26]

363. Deputy Paula Butterly asked the Minister for Health the steps being taken to expedite access and reimbursement for givinostat for children living with Duchenne muscular dystrophy here (details supplied) [44870/26]

209. Deputy David Cullinane asked the Minister for Health the current status of negotiations regarding pricing for reimbursement for skyclarys. [44200/26]

270. Deputy Conor Sheehan asked the Minister for Health the criteria used to determine eligibility for specific medications to treat Parkinson’s disease on the long-term illness scheme; the frequency with which the list is reviewed to include new medications; when the next review will take place; and if she will make a statement on the matter. [44516/26]

707. Deputy Erin McGreehan asked the Minister for Enterprise, Tourism and Employment if his Department has identified opportunities for Ireland to strengthen domestic and EU-based manufacturing capacity for advanced therapies and critical biologic medicines under the framework of the Critical Medicines Act; and if he will make a statement on the matter. [42967/26]

1969. Deputy Barry Ward asked the Minister for Health her views on if delays in the approval of skyclarys as a treatment for friedrich's ataxia aligns with the "equitable access" as outlined in the National Rare Disease Strategy 2025-2030; and if she will make a statement on the matter. [41993/26]

1973. Deputy Barry Ward asked the Minister for Health her views on whether the treatment for friedrich's ataxia falls under an 'unmet need' as set out in the National Rare Diseases Strategy 2025-2030; and if she will make a statement on the matter. [41997/26]

2009. Deputy Emer Currie asked the Minister for Health further to Parliamentary Question No. 1167 of 26 May 2026, to specifically provide the estimated cost to the State of introducing free MART inhalers for this age cohort; and if she will make a statement on the matter. [42332/26]

2049. Deputy Ken O'Flynn asked the Minister for Health whether the forthcoming national medicines disposal programme will include medicine-level cataloguing, reimbursement category tracking, estimated retail value assessment, or analysis of prescribing source; and if she will make a statement on the matter. [42486/26]

2050. Deputy Ken O'Flynn asked the Minister for Health whether her Department or HSE has conducted any international benchmarking regarding medicines waste reduction strategies in comparable EU jurisdictions; and if so, to provide details. [42487/26]

2051. Deputy Ken O'Flynn asked the Minister for Health whether any estimate exists of medicines dispensed under State-funded schemes but not consumed due to non-adherence, therapy change, duplication, early discontinuation, death, hospital admission, or over-prescribing; and if she will make a statement on the matter. [42488/26]

2052. Deputy Ken O'Flynn asked the Minister for Health whether the HSE intends to publish annual reports arising from the new national medicines disposal programme, including estimated financial value and environmental impact of returned medicines. [42489/26]

2089. Deputy Maeve O'Connell asked the Minister for Health for an update on the available services for the disposal of unused or expired medication. [42618/26]

2106. Deputy Paul Nicholas Gogarty asked the Minister for Health the basis on which the HPRA authorised three recent ALURES projects involving potential use of 1,172 dogs and 932 cats over 60 month periods; the scrutiny applied to the necessity, proportionality, and welfare implications of these numbers; the identity of the project holders, establishments, animal sources, and products involved; th…

2111. Deputy Conor D. McGuinness asked the Minister for Health if givinostat will be made available for children with duchenne muscular dystrophy; and if she will make a statement on the matter. [42731/26]

2113. Deputy Pádraig O'Sullivan asked the Minister for Health if considering a policy under the Health (Pricing and Supply of Medical Goods) Act 2013 to qualify parallel imported medicines for reimbursement in Ireland at the same reference price as equivalent medicines supplied through the distribution channels of their original manufacturers; and if she will make a statement on the matter. [42753…